[1] |
Colmenero I, Knöpfel N. Venous malformations in childhood: clinical, histopathological and genetics update[J]. Dermatopathology, 2021, 8(4): 477-493.
|
[2] |
王德明, 苏立新, 范新东. 静脉畸形中国专家共识[J]. 介入放射学杂志, 2019, 28(4): 307-311.
|
[3] |
李龙. 泡沫硬化疗法教程[J]. 北京: 人民军医出版社, 2009: 250.
|
[4] |
约翰·B·马利肯,帕特丽夏·E·巴罗斯,史蒂文·J·菲斯曼. Mulliken和Young脉管疾病血管瘤和脉管畸形[M]. 天津: 天津科技翻译出版公司, 2018: 1146.
|
[5] |
张靖, 单鸿, 欧阳强. 儿科介入放射学[M]. 北京: 中华医学电子音像出版社, 2016: 316.
|
[6] |
Gibson CR, Barnacle AM. Vascular anomalies: special considerations in children[J]. CVIR endovascular, 2020, 3(1): 1-13.
|
[7] |
Zhong LP, Wang LZ. Surgical management of solitary venous malformation in the midcheek region[J]. Oral Surgery Oral Medicine Oral Pathology & Oral Radiology, 2012, 113(3): 422-423.
|
[8] |
Qiu Y, Chen H, Lin X, et al. Outcomes and complications of sclerotherapy for venous malformations[J]. Vascular & Endovascular Surgery, 2013, 47(6): 454.
|
[9] |
郑家伟, 赵怡芳, 秦中平, 等. 口腔颌面-头颈部静脉畸形诊治指南[J]. 中国口腔颌面外科杂志, 2011, 9(6): 510-517.
|
[10] |
Rabe E, Breu FX, Cavezzi A, et al. European guidelines for sclerotherapy in chronic venous disorders[J]. Phlebology. 2014, 29(6): 338-354.
|
[11] |
宋丹, 郭磊, 李静, 等. DSA引导下经皮硬化术治疗儿童唇部低流速静脉畸形的疗效和安全性分析[J]. 医学影像学杂志, 2019, 29(10): 1682-1685.
|
[12] |
Song D, Wu C, Guo L, et al. Efficacy and safety of DSA-guided percutaneous sclerotherapy for venous malformations of penile region in children[J]. Journal of Pediatric Surgery, 2021, 56(3): 601-604.
|
[13] |
Song D, Guo L, Sheng H, et al. DSA guided percutaneous sclerotherapy for children with oropharyngeal low flow venous malformation[J]. Experimental and Therapeutic Medicine, 2020, 19(5): 3405-3410.
|
[14] |
郑月宏, 梅家才. 静脉性疾病聚桂醇硬化实用技术[M]. 北京:中国协和医科大学出版社, 2021: 169.
|
[15] |
陈新龙. PPH术配合聚桂醇硬化注射术治疗内痔疗效观察[J].实用中医药杂志, 2013, 29(10): 864.
|
[16] |
骆晨, 周军. 聚桂醇硬化治疗的应用现状及研究进展[J]. 巴楚医学, 2020, 3(3): 114-117.
|
[17] |
Wang CF, Guo L, Zhang X. Low-dose sclerotherapy with lauromacrogol in the treatment of infantile hemangiomas: a retrospective analysis of 464 cases[J]. Frontiers in Oncology, 2022, 12: 6102.
|
[18] |
廖华胜, 李嘉朋. 无水乙醇结合聚桂醇泡沫硬化剂治疗口腔颌面部高回流型静脉畸形的临床疗效研究[J]. 临床医学工程, 2020, 27(11): 13-14.
|
[19] |
张玥. 超声引导下聚桂醇泡沫硬化治疗静脉畸形的效果观察[J]. 影像研究与医学应用, 2019, 3(11): 167-168.
|
[20] |
Wong K, Connor DE, Andrade OC, et al. Foam bubble size is significantly influenced by sclerosant concentration for polidocanol but not sodium tetradecyl sulphate[J]. Phlebology, 2021, 36(7): 576-587.
|
[21] |
Bai T, Chen Y, Jiang W, et al. Studies on foam decay trend and influence of temperature jump on foam stability in sclerotherapy[J]. Vasc Endovascular Surg, 2017, 52: 98-106.
|
[22] |
汤辉. 聚桂醇泡沫硬化剂制备及临床应用效果[J]. 粘接, 2021, 48(11): 32-35.
|
[23] |
Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins[J]. Dermatol Surg, 2001, 27(1): 58-60.
|
[24] |
Breu FX, Guggenbichler S, Wollmann JC. 2nd European Consensus Meeting on foam sclerotherapy 2006, Tegernsee, Germany[J]. Vasa, 2008, 37 (Suppl 71): 1-29.
|
[25] |
杨耀武, 郑家伟, 孙沫逸, 等. 聚桂醇硬化剂治疗口腔颌面部血管瘤和脉管畸形专家共识[J]. 中国口腔颌面外科杂志, 2018, 16(3): 275-278.
|
[26] |
Anh TT, Nguyen QL, Thi QM, et al. Digital subtraction angiography-guided Foam sclerotherapy with polidocanol for treating superficial venous malformation[J]. Ann Vasc Dis, 2021, 14(3): 231-235.
|
[27] |
Puig S, Aref H, Chigot V, et a1. Classification of venous malformations in children and implications for sclerotherapy[J].Pediatr Radiol, 2003, 33: 99-103.
|
[28] |
丁语, 王梦宇, 靳三丁, 等. 无水乙醇和泡沫硬化剂治疗儿童四肢静脉畸形的体会[J]. 介入放射学杂志, 2019, 28(10): 938-941.
|
[29] |
Zhan T, Cai F, Guo P, et al. Therapeutic evaluation of sclerotherapy for limb venous malformations: a case series[J]. Phlebology, 2020, 35(9): 663-671.
|